8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2014 / Narrative review
This review evaluates evidence regarding dehydroepiandrosterone (DHEA) supplementation. Double-blind, placebo-controlled human trials in the elderly show DHEA increases monocytes, TCRγδ T cells, and NK cells, while improving well-being, muscle strength, bone density, and reducing body fat and skin atrophy. In adrenal insufficiency, it restores hormone levels, lowers total cholesterol, improves insulin sensitivity, and preserves bone mineral density. In women, DHEA improves sexual satisfaction, fertility, and vaginal atrophy, though studies remain inconsistent due to dosing differences, rapid metabolism, and other factors.
Rutkowski K, Sowa P, Rutkowska-Talipska J, et al. Drugs, 2014. PMID 25022952
2014 / Systematic review of randomized controlled trials
A systematic review identified four RCTs evaluating the effect of prunes on gastrointestinal function in constipated and non-constipated subjects. In constipation, 3 weeks of prunes (100 g/day) improved stool frequency (3.5 vs. 2.8 CSBM/week, P = 0.006) and consistency (3.2 vs. 2.8 on the Bristol stool form scale, P = 0.02) compared to psyllium (22 g/day). In non-constipated subjects, prunes softened stool consistency in one trial and increased stool weight (628 g vs. 514 g/72 h wet weight, P = 0.001) in another, with no differences in GI symptoms across trials. Meta-analysis was not appropriate due to heterogeneity, and two trials had unclear risk of bias.
Lever E, Cole J, Scott SM, et al. Aliment Pharmacol Ther, 2014. PMID 25109788
2014 / Narrative review
Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne's disease (JD), a chronic granulomatous enteritis in ruminants. The histopathological picture of JD resembles Crohn's disease (CD), a human chronic inflammatory bowel disease of unresolved etiology. An etiological relevance of MAP for CD has been proposed, and this review discusses evidence regarding whether MAP possesses zoonotic capacity.
Atreya R, Bülte M, Gerlach GF, et al. Int J Med Microbiol, 2014. PMID 25128370
2014 / Narrative review
A literature search on PubMed evaluated clinical and animal studies examining the association between intestinal barrier dysfunction and CNS disorders such as schizophrenia, autism, neurodegenerative diseases, or depression. About half of the evaluated studies reported increased intestinal permeability or mucosal damage, with abnormally high sugar permeability markers reported in up to 43% of children with autism and up to 35% of schizophrenia patients, while another group found no differences. Some reports indicated diets like the gluten-free casein-free diet may normalize the lactulose/mannitol ratio in autism, but no adequately controlled study shows improvement in behavioural symptoms.
Shows an association, not proof of cause and effect.
Julio-Pieper M, Bravo JA, Aliaga E, et al. Aliment Pharmacol Ther, 2014. PMID 25262969
2014 / Narrative review
This review evaluated whether a strict vegan diet provides health advantages compared to vegetarian or overall healthy diets through the gut microbiota. Across studies, the relationship between diet and intestinal microbiota appears to follow a continuum, with vegans showing a microbiota profile most distinct from omnivores, though not always significantly different from vegetarians. The vegan profile uniquely showed a reduced abundance of pathobionts and greater abundance of protective species, with reduced inflammation proposed as a key linking feature. However, it remains unclear whether a therapeutic vegan diet can be prescribed to alter gut microflora for long-term health benefits.
Glick-Bauer M, Yeh MC Nutrients, 2014. PMID 25365383
2014 / Narrative review
This review summarizes current knowledge regarding the mucosal barrier and its role in disease prevention and therapy. It defines intestinal barrier and permeability, details elements affecting permeability, and depicts how diet, bacteria, nutrients, drugs, and other lifestyle factors regulate it. It discusses assessment methods and notes that increased intestinal permeability is associated with critical illness, inflammatory bowel diseases, celiac disease, food allergy, irritable bowel syndrome, and obesity and metabolic diseases.
Bischoff SC, Barbara G, Buurman W, et al. BMC Gastroenterol, 2014. PMID 25407511
2014 / Commentary
This commentary discusses research by Suez et al. (2014) examining the physiological roles of intestinal microbial communities, including energy harvest, glucose homeostasis, and immune development. It highlights their demonstration that artificial sweeteners alter gut microbial communities, resulting in glucose intolerance in both mice and humans.
Bokulich NA, Blaser MJ Cell Metab, 2014. PMID 25440050
2014 / Narrative review
This review provides an updated census of archaeal diversity in the human gastrointestinal tract and their possible role in gut physiology and health. It highlights the order Methanomassiliicoccales, associated with aged populations, which uses mono-, di-, and trimethylamine as final electron acceptors. Trimethylamine is a microbiota-derived product of dietary nutrients (lecithin, choline, TMAO, L-carnitine) from which trimethylaminuria and cardiovascular disease seem to originate via its oxidized liver-derived form. These characteristics support interest in exploring these methanogenic species as archaebiotics.
Gaci N, Borrel G, Tottey W, et al. World J Gastroenterol, 2014. PMID 25473158
2013 / Narrative review
This review examines the epidemiology of Clostridium difficile infection (CDI) in humans and animals. C. difficile has been found in 20-40% of meat products in Canada and the USA, indicating possible food-borne transmission, though not proven. PCR ribotype 078 is the most common ribotype in pigs (83% in one US study) and cattle (up to 100%), and is the third most common ribotype in human infection in Europe, where human and pig strains are genetically identical. The authors suggest that a 'One Health' approach is needed to address human, animal, and environmental factors.
Shows an association, not proof of cause and effect.
Squire MM, Riley TV Curr Top Microbiol Immunol, 2013. PMID 22695920
2013 / Narrative review
This review examines the chemical constituents, biological activities, molecular targets, and clinical potential of turmeric. Curcumin constitutes 2-5% of turmeric, though some activities of turmeric are curcumin-independent. Clinical trials have demonstrated the efficacy of turmeric against human ailments including lupus nephritis, cancer, diabetes, irritable bowel syndrome, acne, and fibrosis.
Gupta SC, Sung B, Kim JH, et al. Mol Nutr Food Res, 2013. PMID 22887802
2013 / Narrative review
This review examines inflamm-ageing, the chronic low-grade inflammation characteristic of ageing that contributes to health decline and age-related disease. It discusses the roles of senescent cells, metaflammation, gut microbiota, and nutrition in modulating this phenomenon across the human lifespan. The authors emphasize that gut microbiota and nutrition should be utilized to slow inflamm-ageing, potentially promoting healthy ageing and extending lifespan.
Cevenini E, Monti D, Franceschi C Curr Opin Clin Nutr Metab Care, 2013. PMID 23132168
2013 / Narrative review of clinical trials
This review examines clinical trials from the past quarter century addressing the pharmacokinetics, safety, and efficacy of curcumin in humans. Promising effects were noted in patients with diverse pro-inflammatory diseases, such as cancer, cardiovascular disease, arthritis, gastrointestinal conditions, diabetes, and renal diseases. Dose-escalating studies showed curcumin is safe at doses as high as 12 g/day over 3 months. Curcumin modulates numerous human signaling molecules, including pro-inflammatory cytokines, apoptotic proteins, NF-κB, COX-2, STAT3, C-reactive protein, and triglycerides.
Gupta SC, Patchva S, Aggarwal BB AAPS J, 2013. PMID 23143785
2013 / Narrative review
This review examines short chain fatty acids (SCFAs), their receptors, and their relationship with metabolism. In humans, SCFAs are largely generated through the fermentation of carbohydrates and proteins in the colon, allowing energy salvage from otherwise indigestible foods. Recently identified SCFA receptors, FFAR2 and FFAR3, are expressed in the gut epithelium as well as metabolically important tissues including adipose tissue and pancreatic islets.
Layden BT, Angueira AR, Brodsky M, et al. Transl Res, 2013. PMID 23146568
2013 / Narrative review
A review examined the gastrointestinal safety of prescription and over-the-counter (OTC) NSAIDs. Long-term endoscopy studies report ulcer rates from 15% to 35% with NSAIDs, while serious outcomes are exceedingly rare, and mega-trials indicate NSAID-induced gastric bleeding occurs in fewer than 1 in 200 subjects taking them for a year. OTC ibuprofen and diclofenac had symptomatic side effects comparable to placebo, with ibuprofen being remarkably well tolerated. The authors note recent studies suggesting OTC NSAIDs should be taken on a fasting stomach rather than with food.
Bjarnason I Int J Clin Pract Suppl, 2013. PMID 23163547
2013 / Narrative review
This review discusses the CODEX Alimentarius definition of dietary fiber, which includes nondigestible carbohydrate polymers with a degree of polymerization of 3 or more if they demonstrate health benefits. It emphasizes the need for scientific consensus on physiological effects such as laxation, gut health, attenuation of blood lipids, glucose, and insulin, and large bowel fermentation. Research protocols to demonstrate these benefits require evidence-based reviews, well-controlled randomized trials, and animal studies for mechanisms. The definition highlights that combining fiber-rich and fiber-fortified foods can help address the global fiber consumption gap within allowed energy levels.
Jones JM Adv Nutr, 2013. PMID 23319118
2013 / Narrative review
This review synthesized human epidemiological data, clinical trials, and animal studies evaluating the anti-inflammatory roles of dietary fibers. High-fiber diets were linked to lower body weight and reduced inflammatory markers, while fermentable fibers also demonstrated weight-unrelated systemic and local intestinal anti-inflammatory actions. Synbiotics showed no convincing evidence of higher efficacy compared to fiber alone. Adverse effects were not observed at the fiber intakes tested, although individuals with Crohn's disease may exhibit greater sensitivity to inulin.
Kuo SM Adv Nutr, 2013. PMID 23319119
2013 / Narrative review
This review evaluates curcumin, a component of turmeric, as an alternative to expensive injectable TNF-α blockers approved for inflammatory conditions. The authors report that curcumin is orally bioavailable and highly safe in humans, and can block TNF-α production and action across in vitro models, animal models, and human studies. Evidence is discussed regarding curcumin's activity against diseases treated with TNF blockers, along with mechanisms inhibiting TNF production and signalling pathways.
Aggarwal BB, Gupta SC, Sung B Br J Pharmacol, 2013. PMID 23425071
2013 / Review of epidemiological and microbiological studies (2008-2012)
Researchers reviewed recent epidemiological studies and microbiological research published between 2008 and 2012 regarding isoflavone intake, equol-producing flora, and prostate cancer (PCa) risk. Five out of six articles showed a significant association of isoflavones with a decreased risk of PCa, and two of these consistently reported that equol-producers have a significantly reduced risk. Additionally, five human intestinal bacteria capable of converting daidzein into equol were identified within the evaluated timeframe.
Shows an association, not proof of cause and effect.
Sugiyama Y, Masumori N, Fukuta F, et al. Asian Pac J Cancer Prev, 2013. PMID 23534704
2013 / Narrative review
This review examines the pharmacology, efficacy, adverse effects, and dosage of curcuminoids and standardized curcumin extracts. Early human clinical trials suggest potential beneficial effects for conditions such as dyspepsia, peptic ulcer, inflammatory bowel disease, rheumatoid arthritis, osteoarthritis, uveitis, orbital pseudotumor, and pancreatic cancer. Curcumin is generally well-tolerated, with nausea and diarrhea being the most common side effects. The authors note that late-phase clinical trials are still required to confirm most beneficial effects.
Asher GN, Spelman K Altern Ther Health Med, 2013. PMID 23594449
2013 / Narrative review
This review evaluates the gastroprotective and medicinal effects of ginger (Zingiber officinale Roscoe). Animal studies indicate ginger prevents gastric ulcers induced by NSAIDs, reserpine, ethanol, stress, acetic acid, and Helicobacter pylori. Preclinical and clinical studies show anti-emetic effects, though conflicting findings in chemotherapy-induced nausea, vomiting, and motion sickness preclude firm conclusions regarding broad-spectrum efficacy. Further research is needed to firmly establish its utility as a gastroprotective agent in humans.
Haniadka R, Saldanha E, Sunita V, et al. Food Funct, 2013. PMID 23612703
2013 / Narrative review
This review summarizes preclinical and clinical studies evaluating the rhizome of Zingiber officinale (ginger) for preventing nausea and vomiting against various emetogenic stimuli. While ginger has shown antiemetic effects, conflicting reports—particularly regarding motion sickness and chemotherapy-induced nausea and vomiting—prevent firm conclusions. The authors address published study limitations and highlight areas needing further investigation for future clinical application.
Palatty PL, Haniadka R, Valder B, et al. Crit Rev Food Sci Nutr, 2013. PMID 23638927
2013 / Commentary / narrative review of a human trial
This commentary summarizes a human trial assessing the effects of whole grain barley, brown rice, or their combination on fecal microbiota and metabolic/inflammatory markers. Whole grain intake increased gut microbial diversity and induced compositional alterations. The combination of barley and brown rice reduced plasma interleukin-6 (IL-6), which was linked to compositional features of the gut microbiota.
Walter J, Martínez I, Rose DJ Gut Microbes, 2013. PMID 23645316
2013 / Narrative review
This review summarizes environmental and lifestyle risk factors for gastric cancer. Helicobacter pylori is the primary carcinogen, alongside smoking and salt as strong independent risk factors. Red meat and high fat intake are reported to increase gastric cancer risk, whereas fresh fruits, vegetables from the allium family, and micronutrients such as selenium and vitamin C reduce the risk. Obesity contributes to gastric cardia carcinogenesis, while physical activity is considered protective.
Shows an association, not proof of cause and effect.
Lee YY, Derakhshan MH Arch Iran Med, 2013. PMID 23725070
2013 / Narrative review
This review evaluates the health benefits and nutrient density of green and gold kiwifruit cultivars. Kiwifruit as part of a healthy diet may increase HDL cholesterol, decrease triglycerides, platelet aggregation, and elevated blood pressure, while green kiwifruit aids digestion and laxation. Consuming gold kiwifruit with iron-rich meals improves poor iron status, and kiwifruit intake may support immune function and reduce cold or flu-like illness incidence and severity in children and older adults. However, kiwifruit is allergenic, with reported reactions ranging from mild symptoms to severe events.
Stonehouse W, Gammon CS, Beck KL, et al. Can J Physiol Pharmacol, 2013. PMID 23746068